64 Regions of the Genome That Increase Risk for Bipolar Disorder Identified
neurosciencenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neurosciencenews.com Daily Mail and Mail on Sunday newspapers.
Researchers identify regions of genome that increase risk for bipolar disorder
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Published: May 13, 2021 By Alex Keown
Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinical development focusing on global brands research and development at Allergan and Actavis.
CARMAT – France-based CARMAT’s board of directors is reorganizing its governance and appointed three new directors. The company tapped Florent Battistella, David Coti and John B. Hernandez as directors. Battistella founded Nisima, a holding company, which holds stakes in various firms, notably
Keyhole surgery for liver cancer results in better outcomes and quality of life
Those who had tumors removed from their livers with keyhole surgery had fewer complications, a better quality of life and similar long-term oncologic outcomes, a new PhD thesis shows.
In many patients with colon and rectal cancer, cancer spreads to the liver. Several patients are now being operated on using a technique called keyhole or laparoscopic surgery, where the surgeon merely attempts to remove tumors with sufficient surrounding health tissue. This type of surgery is called a laparoscopic parenchyma-sparing liver resection.
But do these kinds of keyhole surgeries work just as well as operations where the patient is opened up? Does the patient live just as long afterwards? What about complications and quality of life? This is what Davit L. Aghayan wanted to find out when he started his PhD at the University of Oslo.